No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Carcinoid Tumor / drug therapy*
-
Carcinoid Tumor / mortality
-
Humans
-
Interferon Type I / adverse effects
-
Interferon Type I / therapeutic use*
-
Intestinal Neoplasms / drug therapy*
-
Intestinal Neoplasms / mortality
-
Intestine, Small / pathology
-
Neurosecretory Systems / drug effects
-
Octreotide / adverse effects
-
Octreotide / therapeutic use*
-
Pancreatic Neoplasms / drug therapy*
-
Pancreatic Neoplasms / mortality
-
Recombinant Proteins
Substances
-
Antineoplastic Agents
-
Interferon Type I
-
Recombinant Proteins
-
Octreotide